Lomonosova Anna V, Ulitin Andrei B, Kazakov Alexei S, Mirzabekov Tajib A, Permyakov Eugene A, Permyakov Sergei E
Institute for Biological Instrumentation of the Russian Academy of Sciences, Pushchino, Moscow region, Russia.
Antherix, Pushchino, Moscow region, Russia.
PLoS One. 2017 Jan 19;12(1):e0170349. doi: 10.1371/journal.pone.0170349. eCollection 2017.
Small antibody mimetics, or alternative binding proteins (ABPs), extend and complement antibody functionality with numerous applications in research, diagnostics and therapeutics. Given the superiority of ABPs, the last two decades have witnessed development of dozens of alternative protein scaffolds (APSs) for the design of ABPs. Proteins from extremophiles with their high structural stability are especially favorable for APS design. Here, a 10X mutant of the 50S ribosomal protein L35Ae from hyperthermophilic archaea Pyrococcus horikoshii has been probed as an APS. A phage display library of L35Ae 10X was generated by randomization of its three CDR-like loop regions (repertoire size of 2×108). Two L35Ae 10X variants specific to a model target, the hen egg-white lysozyme (HEL), were isolated from the resulting library using phage display. The affinity of these variants (L4 and L7) to HEL ranges from 0.10 μM to 1.6 μM, according to surface plasmon resonance data. While L4 has 1-2 orders of magnitude lower affinity to HEL homologue, bovine α-lactalbumin (BLA), L7 is equally specific to HEL and BLA. The reference L35Ae 10X is non-specific to both HEL and BLA. L4 and L7 are more resistant to denaturation by guanidine hydrochloride compared to the reference L35Ae 10X (mid-transition concentration is higher by 0.1-0.5 M). Chemical crosslinking experiments reveal an increased propensity of L4 and L7 to multimerization. Overall, the CDR-like loop regions of L35Ae 10X represent a proper interface for generation of functional ABPs. Hence, L35Ae is shown to extend the growing family of protein scaffolds dedicated to the design of novel binding proteins.
小型抗体模拟物或替代结合蛋白(ABP)扩展并补充了抗体的功能,在研究、诊断和治疗领域有众多应用。鉴于ABP的优越性,在过去二十年中见证了数十种用于设计ABP的替代蛋白质支架(APS)的开发。来自极端嗜热菌的具有高结构稳定性的蛋白质尤其有利于APS设计。在此,对来自嗜热古菌火球菌的50S核糖体蛋白L35Ae的10倍突变体进行了作为APS的探索。通过对其三个类互补决定区(CDR)样环区域进行随机化,构建了L35Ae 10X的噬菌体展示文库(库容量为2×108)。使用噬菌体展示从所得文库中分离出两种对模型靶标鸡蛋清溶菌酶(HEL)具有特异性的L35Ae 10X变体。根据表面等离子体共振数据,这些变体(L4和L7)对HEL的亲和力范围为0.10 μM至1.6 μM。虽然L4对HEL同源物牛α-乳白蛋白(BLA)的亲和力低1-2个数量级,但L7对HEL和BLA具有同等特异性。参考L35Ae 10X对HEL和BLA均无特异性。与参考L35Ae 10X相比,L4和L7对盐酸胍变性更具抗性(中间转变浓度高0.1-0.5 M)。化学交联实验表明L4和L7多聚化的倾向增加。总体而言,L35Ae 10X的类CDR环区域代表了产生功能性ABP的合适界面。因此,L35Ae被证明扩展了致力于设计新型结合蛋白的不断增长的蛋白质支架家族。
Protein Eng Des Sel. 2014-10
Biochem Biophys Res Commun. 2006-5-12
J Mol Biol. 2011-4-16
Mol Biosyst. 2016-7-19
Annu Rev Pharmacol Toxicol. 2015
Crit Rev Biotechnol. 2016
Curr Opin Struct Biol. 2014-8
Cancer Genomics Proteomics. 2013
Nucleic Acids Res. 2013-5-13